Sequenom's Share Price Doubles in June as Caliper Continues to Sag

Jul 03, 2008

NEW YORK (GenomeWeb News) – Sequenom’s stock was by far the biggest gainer — more than doubling its price — in June among the 36 companies that comprise the GenomeWeb Daily News Index.

In a tough month for the stock market, in general, Sequenom’s shares rose 107.5 percent. On the other end of the spectrum, shares of Caliper Life Sciences continued to decline, falling 27.6 percent for the month of June.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Not Mentioning It

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

Lost Some Value There

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Slight Budget Trim

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

This Week in PLOS

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Main menu